ObsEva is a Swiss-based, specialty biopharmaceutical company dedicated to the development of innovative drugs for women’s reproductive medicine. ObsEva’s main focus is on therapies for preterm labor. ObsEva was founded in 2012 by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a clinician specialised in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. He was previously Co-Founder and CEO of PregLem. André Chollet is a medicinal and pharmaceutical chemist with over 30 years of experience gained in diverse roles within the biopharmaceutical industry, including at Biogen, GSK and Merck Serono.